v3.25.3
Condensed Consolidated Balance Sheet (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash, cash equivalents and current restricted cash $ 415,198 $ 431,936
Accounts receivable, net 94,580 118,017
Inventory, net 64,954 56,797
Other current assets and prepaid expenses 52,398 55,339
Total current assets 627,130 662,089
Property, plant and equipment, net 74,994 70,134
Intangible assets, net 535,378 616,613
In-process research and development 195,000 195,000
Goodwill 484,032 529,252
Investments 13,367 54,584
Operating lease right-of-use assets 45,681 54,003
Other assets 19,926 18,537
Total assets 1,995,508 2,200,212
Current liabilities:    
Accounts payable 50,827 47,071
Accrued expenses 95,603 118,357
Current maturities of operating leases 10,106 12,649
Current portion of convertible notes 0 170
Current portion of lines of credit and notes payable 12,785 14,849
Total current liabilities 169,321 193,096
Operating lease liabilities 36,273 48,849
Long term portion of convertible notes 82,699 173,606
Senior secured notes 246,224 245,576
Deferred tax liabilities 130,341 140,799
Other long-term liabilities 25,160 32,838
Total long-term liabilities 520,697 641,668
Total liabilities 690,018 834,764
Equity:    
Common Stock - $0.01 par value, 1,250,000,000 shares authorized; 798,901,457 and 701,350,447 shares issued at September 30, 2025 and December 31, 2024, respectively 7,990 7,015
Treasury Stock - 30,199,907, and 29,799,907 shares at September 30, 2025 and December 31, 2024, respectively (2,390) (1,791)
Additional paid-in capital 3,584,789 3,481,364
Accumulated other comprehensive loss (25,466) (56,130)
Accumulated deficit (2,259,433) (2,065,010)
Total shareholders’ equity 1,305,490 1,365,448
Total liabilities and equity $ 1,995,508 $ 2,200,212

Source

HTML PDF
ZIP